CytoCan

CytoCan

Uses a modular platform called abzed to create fusion proteins with multiple functions.

Market cap
-
Enterprise valuation
CAD8—11m (Dealroom.co estimates Feb 2023.)
Shaanxi China (HQ)
  • Edit
DateInvestorsAmountRound
*

CNY10.0m

Seed
Total FundingCAD1.9m

Recent News about CytoCan

Edit